Wells Fargo & Company Gelesis Holdings, Inc. Transaction History

Wells Fargo & Company

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 12, 2023	BUY	$0.11 - $0.52 $356 - $1,685	3,241 New	3,241 $0
Q3 2022 Nov 14, 2022	SELL	$0.08 - $1.34 $10 - $175	-131 Reduced 53.69%	113 $0
Q2 2022 Aug 12, 2022	BUY	N/A	102 Added 71.83%	244 $0
Q1 2022 May 16, 2022	BUY	N/A	142 New	142 $1,000

4.7K

Ticker GLS
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 72,946,704
Market Cap $1.46M
Description
Gelesis Holdings Inc., a commercial stage biotherapeutics company, developing a biomimicry to treat the genesis of obesity and GI-related chronic diseases. The company also provides PLENITY, an orally administered, non-stimulant, and non-systemic aid for weight management. In addition, it offers a product for obesity and overweight and a pipelin...

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

Stay updated on Wells Fargo & Company with notifications on news.